Becoming agile in experience measurement
The customer experience is pharma’s new competitive battleground – trust is its key metric, and the prizes will go to the nimble
Close log in window
The digital therapeutics reimbursement process is maturing but complexity and risk remain to be managed
As big pharma ponders the right sizing of its post-pandemic field forces, can it learn from smaller, leaner industry peers about doing more ...
Now that CGT is proving its worth, the next task for pharma is working out the best ways to commercialise it
The future looks bright for biosimilars in an age of crisis over healthcare affordability
